Annual Book Value
$607.00 K
-$19.83 M-97.03%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual book value is $607.00 thousand, with the most recent change of -$19.83 million (-97.03%) on December 31, 2023.
- During the last 3 years, CYCC annual book value has fallen by -$32.65 million (-98.17%).
- CYCC annual book value is now -98.95% below its all-time high of $57.97 million, reached on December 31, 2007.
Performance
CYCC Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
-$970.00 K
-$1.97 M-197.10%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly book value is -$970.00 thousand, with the most recent change of -$1.97 million (-197.10%) on September 30, 2024.
- Over the past year, CYCC quarterly book value has dropped by -$1.58 million (-259.80%).
- CYCC quarterly book value is now -101.27% below its all-time high of $76.14 million, reached on March 31, 2007.
Performance
CYCC Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
CYCC Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.0% | -259.8% |
| 3 y3 years | -98.2% | -106.6% |
| 5 y5 years | -96.0% | -106.6% |
CYCC Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.4% | at low | -102.6% | +56.0% |
| 5 y | 5-year | -98.4% | at low | -102.0% | +56.0% |
| alltime | all time | -99.0% | +100.9% | -101.3% | +98.5% |
Cyclacel Pharmaceuticals Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$970.00 K(-197.1%) |
| Jun 2024 | - | $999.00 K(-145.3%) |
| Mar 2024 | - | -$2.21 M(-463.4%) |
| Dec 2023 | $607.00 K(-97.0%) | $607.00 K(-85.9%) |
| Sep 2023 | - | $4.30 M(-55.4%) |
| Jun 2023 | - | $9.63 M(-34.2%) |
| Mar 2023 | - | $14.64 M(-28.3%) |
| Dec 2022 | $20.43 M(-45.8%) | $20.43 M(-23.1%) |
| Sep 2022 | - | $26.56 M(-12.1%) |
| Jun 2022 | - | $30.21 M(-9.6%) |
| Mar 2022 | - | $33.41 M(-11.4%) |
| Dec 2021 | $37.69 M(+13.3%) | $37.69 M(-8.9%) |
| Sep 2021 | - | $41.36 M(-4.3%) |
| Jun 2021 | - | $43.22 M(-10.1%) |
| Mar 2021 | - | $48.05 M(+44.5%) |
| Dec 2020 | $33.26 M(+184.3%) | $33.26 M(+36.1%) |
| Sep 2020 | - | $24.44 M(-8.1%) |
| Jun 2020 | - | $26.58 M(+155.8%) |
| Mar 2020 | - | $10.39 M(-11.2%) |
| Dec 2019 | $11.70 M(-23.4%) | $11.70 M(-15.6%) |
| Sep 2019 | - | $13.85 M(-11.9%) |
| Jun 2019 | - | $15.73 M(-10.4%) |
| Mar 2019 | - | $17.55 M(+14.9%) |
| Dec 2018 | $15.27 M(-29.8%) | $15.27 M(-8.0%) |
| Sep 2018 | - | $16.60 M(-10.9%) |
| Jun 2018 | - | $18.62 M(-8.7%) |
| Mar 2018 | - | $20.39 M(-6.3%) |
| Dec 2017 | $21.77 M(+52.5%) | $21.77 M(-7.2%) |
| Sep 2017 | - | $23.46 M(+101.6%) |
| Jun 2017 | - | $11.64 M(-9.2%) |
| Mar 2017 | - | $12.82 M(-10.2%) |
| Dec 2016 | $14.27 M(-24.2%) | $14.27 M(-15.7%) |
| Sep 2016 | - | $16.94 M(+28.7%) |
| Jun 2016 | - | $13.16 M(-17.2%) |
| Mar 2016 | - | $15.90 M(-15.6%) |
| Dec 2015 | $18.84 M(-13.2%) | $18.84 M(-12.8%) |
| Sep 2015 | - | $21.60 M(-10.4%) |
| Jun 2015 | - | $24.10 M(-10.8%) |
| Mar 2015 | - | $27.03 M(+24.6%) |
| Dec 2014 | $21.69 M(-22.6%) | $21.69 M(-12.0%) |
| Sep 2014 | - | $24.64 M(-16.7%) |
| Jun 2014 | - | $29.59 M(+18.5%) |
| Mar 2014 | - | $24.98 M(-10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $28.02 M(+179.7%) | $28.02 M(-3.4%) |
| Sep 2013 | - | $29.01 M(-6.2%) |
| Jun 2013 | - | $30.93 M(+202.2%) |
| Mar 2013 | - | $10.23 M(+2.2%) |
| Dec 2012 | $10.02 M(-48.6%) | $10.02 M(-24.3%) |
| Sep 2012 | - | $13.23 M(-12.1%) |
| Jun 2012 | - | $15.05 M(-18.8%) |
| Mar 2012 | - | $18.54 M(-4.9%) |
| Dec 2011 | $19.50 M(-21.8%) | $19.50 M(-15.3%) |
| Sep 2011 | - | $23.01 M(+38.2%) |
| Jun 2011 | - | $16.65 M(-18.3%) |
| Mar 2011 | - | $20.38 M(-18.2%) |
| Dec 2010 | $24.92 M(+324.6%) | $24.92 M(+100.6%) |
| Sep 2010 | - | $12.42 M(-12.2%) |
| Jun 2010 | - | $14.15 M(-18.0%) |
| Mar 2010 | - | $17.26 M(+194.1%) |
| Dec 2009 | $5.87 M(-71.6%) | $5.87 M(-26.1%) |
| Sep 2009 | - | $7.95 M(-3.7%) |
| Jun 2009 | - | $8.25 M(-45.7%) |
| Mar 2009 | - | $15.20 M(-26.4%) |
| Dec 2008 | $20.64 M(-64.4%) | $20.64 M(-30.7%) |
| Sep 2008 | - | $29.77 M(-31.4%) |
| Jun 2008 | - | $43.41 M(-16.4%) |
| Mar 2008 | - | $51.94 M(-10.4%) |
| Dec 2007 | $57.97 M(+7.5%) | $57.97 M(-15.5%) |
| Sep 2007 | - | $68.57 M(-5.8%) |
| Jun 2007 | - | $72.83 M(-4.4%) |
| Mar 2007 | - | $76.14 M(+41.2%) |
| Dec 2006 | $53.92 M(+1218.6%) | $53.92 M(-9.1%) |
| Sep 2006 | - | $59.33 M(-7.6%) |
| Jun 2006 | - | $64.24 M(+153.0%) |
| Mar 2006 | - | $25.39 M(+520.9%) |
| Dec 2005 | $4.09 M(-90.7%) | $4.09 M(-77.5%) |
| Sep 2005 | - | $18.19 M(-41.9%) |
| Jun 2005 | - | $31.30 M(-15.7%) |
| Mar 2005 | - | $37.15 M(-15.8%) |
| Dec 2004 | $44.12 M(-168.0%) | $44.12 M(+64.1%) |
| Sep 2004 | - | $26.88 M(-18.8%) |
| Jun 2004 | - | $33.10 M(-14.3%) |
| Mar 2004 | - | $38.62 M(-159.6%) |
| Dec 2003 | -$64.84 M(+34.7%) | -$64.84 M |
| Dec 2002 | -$48.13 M(+32.7%) | - |
| Dec 2001 | -$36.26 M(+42.8%) | - |
| Dec 2000 | -$25.38 M | - |
FAQ
- What is Cyclacel Pharmaceuticals annual book value?
- What is the all time high annual book value for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual book value year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly book value year-on-year change?
What is Cyclacel Pharmaceuticals annual book value?
The current annual book value of CYCC is $607.00 K
What is the all time high annual book value for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual book value is $57.97 M
What is Cyclacel Pharmaceuticals annual book value year-on-year change?
Over the past year, CYCC annual book value has changed by -$19.83 M (-97.03%)
What is Cyclacel Pharmaceuticals quarterly book value?
The current quarterly book value of CYCC is -$970.00 K
What is the all time high quarterly book value for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly book value is $76.14 M
What is Cyclacel Pharmaceuticals quarterly book value year-on-year change?
Over the past year, CYCC quarterly book value has changed by -$1.58 M (-259.80%)